Analysis of the ul97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance

Journal of Infectious Diseases

Volumn 171, Issue 3, 1995, Pages 576-583

  Chou, Sunwen ^a,b,c   Erice, Alejo ^a,b,c   Colin Jordan, M ^a,b,c   Vercellotti, Gregory M ^a,b,c   Michels, Kendall R ^a,b,c   Talarico, Christine L ^a,b,c   Stanat, Sylvia C ^a,b,c   Biron, Karen K ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b University of Minnesota   (United States)

^c Burroughs Wellcome Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR; PHOSPHOTRANSFERASE; RESTRICTION ENDONUCLEASE; VIRUS ENZYME;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CODON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG RESISTANCE; FATALITY; GENE AMPLIFICATION; GENE MUTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CASE REPORT; CODON; CYTOMEGALOVIRUS; DRUG RESISTANCE; GANCICLOVIR; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOTRANSFERASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028940302     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/171.3.576     Document Type: Article

References (15)

1. Drew WL, Miner RC. Busch DF. et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 1991;163:716-9
2. Erice A, Chou S. Biron KK, Stanat SC, Balfour HH, Jordan MC. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 1989;320:289-93
3. Chee MS. Lawrence GL. Barrell BG. Alpha-, beta- and gamma-herpes-viruses encode a putative phosphotransferase. J Gen Virol 1989;70: 1151-60
4. Littler E, Stuart AD, Chee MS. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 1992;358:160-2
5. Sullivan V. Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992;358:162-4
6. Lurain N, Spa fiord LE, Thompson KD. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J Virol 1994;68:4427-31
7. Lurain NS. Thompson KD, I lolmes EW, Read GS. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol 1992;66:7146-52
8. Sullivan V, Biron KK, Talarico C, et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother 1993;37:19-25
9. Biron KK, Stanat SC, Sorrell JB, et al. Metabolic activation of the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyI)-guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci USA 1985;82:2473-7
10. Stanat SC, Reardon JE. Erice A. Jordan MC, Drew WL, Biron KK. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother 1991;35:2191 — 7
11. Chou S, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes, J Infect Dis 1991:163:1229-34
12. Kwok S, Kellogg DE, McKinney N, et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type I model studies. Nucleic Acids Res 1990; 18:999-1005
13. Chou S. Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region. J Clin Microbiol 1992;30:2307-10
14. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1988;241:42-52
15. Knighton DR. Zheng J, Ten Byck LF. Xuong NH, Taylor SS. Sowadski JM. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991;253:414-20